Published in Lab Business Week, July 17th, 2005
Study 1: Blood VEGF levels denote melanoma progression and remission.
"Angiogenesis has been reported as a parameter of potential prognostic value in solid tumors, as it may facilitate tumor growth and metastasis. One of the most important growth factors involved in angiogenesis is vascular endothelial growth factor (VEGF)," according to researchers in France, who conducted a study "to determine the predictive value of circulating VEGF levels in a cohort of patients with melanoma."
"In a prospective cohort study, 324 patients with cutaneous...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-07-17)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.